• gmp-verlag.de
  • GMP MANUAL Login
  • Shopping cart
Stay informed!

You’d like to be regularly informed on the latest developments in Good Manufacturing Practices?

 

Subscribe to our free GMP Newsletter LOGFILE!

>>> REGISTER NOW

The New USP <1231>
Water for Pharmaceutical Purposes

a detailed Overview

>>> ORDER NOW

Award for the
GMP Compliance Adviser

GMP knowledge that convinces.

Image

On 7 June 2016 Maas & Peither GMP Publishing has received a

SIPAward in the category
"Best New Success Story" and was awarded with the 3rd place.

The GMP MANUAL (now: GMP Compliance Adviser) impressed the jury with "Safe Drugs through Better GMP Understanding".


GMP Compliance Adviser

GMP in Practice: 24 chapters written by internationally renowned industry experts.

 

GMP Regulations: 8 chapters with the most important GMP guidelines and regulations.

 

Image

>>> READ MORE

TOP 5 GMP Downloads

1. Questionnaire for preparing GMP-inspections
More than 650 typical questions related to audits and inspections.


2. GDP Audit Checklist
More than 700 questions with reference to regulations.


3. GMP Fundamentals
A quick and comprehensive overview of the complex world of GMP.


4. Industry Guide to handle OOX Test Results
Every single step of the OOX process.


5. The New USP <1231>: Water for Pharmaceutical Purposes
A compact overview of the contents of the new version of USP <1231>.


>>> More Downloads

News about GMP/cGMP

2017-05-02

PIC/S reaffirms position on proposed EU ATMP GMP Guidelines

Following PIC/S strong criticism on the proposed stand-alone ATMP (Advanced Therapy Medicinal Product) GMP Guidelines of the European Commission (we reported), PIC/S has now published a second letter to the EC on its website.

 

The second letter was sent in response to a reply from the European Commission. Initially PIC/S has criticised the content of the ATMP GMP Guidelines to not only lower GMP standards for ATMP at the risk of patients but also to lead to an internationally non-harmonised approach to the implementation of GMP for ATMPs.

In its latest letter, PIC/S has reaffirmed its position and highlights again gaps relating to patient safety. Besides other concerns expressed therein, this major concern of PIC/S and its members has obviously not been taken into account by the EC so far.

This time an Annex was enclosed to the letter that details a non-exhaustive summary of critical outstanding points that could be of risk to patient safety.

Obviously the EC has proposed to explain and discuss the draft Guidelines with non-EU PIC/S Members, as PIC/S is responding to that matter and is asking for the next steps to be taken. “A reply to our proposal for a joint Working Group has not been received” it says in the letter. Furthermore it is said that “Clarification on the scope of the co-operation you propose would be welcome. It would also be appreciated if the latest version of the draft Guidelines could be shared as soon as possible to allow us at least to comment prior to publication. A discussion after the finalisation and publication of the Guidelines would have little purpose.

Another important concern that has been addressed once more was the risk of de-harmonisation should it come down to lower GMP standards for ATMPs. PIC/S and its members fear that this could lead to serious consequences to the current global regulatory framework.

The enclosed Annex lists a summary of 17 critical points impacting patient safety.

Source:

PIC/S: News

Comments
No comment has yet been written about this news.